US EditionPublished • loading... • Updated
The Rfzo and the Astrazeneca Company Signed an Agreement on Innovative Drugs for Oncology Patients in Serbia
Summary by Dnevni List Danas
4 Articles
4 Articles
An agreement was signed in Belgrade today between the Republic Fund for Health Insurance and the company AstraZeneca, according to which innovative drugs for oncology patients will be on the list of the RFZO.
·Belgrade, Serbia
Read Full Article
He added that he is satisfied for the citizens, even though it is about expensive medicines that will be felt in the budget, euronews serbia, euronews serbia, euronews serbia, euronews serbia, euronews, euronews
The Rfzo and Astrazeneca Signed an Agreement on Innovative Medicines for Oncology Patients in Serbia
An agreement was signed between the Republic Health Insurance Fund and AstraZeneca, according to which innovative drugs for oncology patients will be on the RFZO list.
·Novi Beograd, Serbia
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
